Exact Mass: 465.25488040000005
Exact Mass Matches: 465.25488040000005
Found 500 metabolites which its exact mass value is equals to given mass value 465.25488040000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPC(14:1(9Z)/0:0)
C22H44NO7P (465.28552440000004)
LysoPC(14:1(9Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(14:1(9Z)), in particular, consists of one chain of myristoleic acid at the C-1 position. The myristoleic acid moiety is derived from milk fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins. [HMDB] LysoPC(14:1(9Z)) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. Lysophosphatidylcholines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) position. Fatty acids containing 16, 18 and 20 carbons are the most common. LysoPC(14:1(9Z)), in particular, consists of one chain of myristoleic acid at the C-1 position. The myristoleic acid moiety is derived from milk fats. Lysophosphatidylcholine is found in small amounts in most tissues. It is formed by hydrolysis of phosphatidylcholine by the enzyme phospholipase A2, as part of the de-acylation/re-acylation cycle that controls its overall molecular species composition. It can also be formed inadvertently during extraction of lipids from tissues if the phospholipase is activated by careless handling. In blood plasma significant amounts of lysophosphatidylcholine are formed by a specific enzyme system, lecithin:cholesterol acyltransferase (LCAT), which is secreted from the liver. The enzyme catalyzes the transfer of the fatty acids of position sn-2 of phosphatidylcholine to the free cholesterol in plasma, with formation of cholesterol esters and lysophosphatidylcholine. Lysophospholipids have a role in lipid signaling by acting on lysophospholipid receptors (LPL-R). LPL-Rs are members of the G protein-coupled receptor family of integral membrane proteins.
[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
Glycyl-histidyl-arginyl-proline
Luminespib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
(7S,13E,16S,17R,18S,19E)-22-oxa-(12)-cytochalasa-5,13,19-triene-1,21-dione-7,17-dihydroxy-16,18-dimethyl-10-phenyl|cytochalasin Z8
C28H35NO5 (465.25151000000005)
18-methoxyeladine|6beta,16beta-dihydroxy-7,8-methylenedioxy-1alpha,14alpha,18-trimethoxy-N-ethylaconitane
1alpha,6beta-dihydroxy-7,8-methylenedioxy-14alpha,16beta,18beta-trimethoxy-N-ethylaconitane|uraphine
(6R,16S,18R,21R)-18,21-dihydroxy-16,18-dimethyl-10-phenyl[11]cytochalasa-13(E),19(E)-diene-1,7,17-trione|zygosporin D
C28H35NO5 (465.25151000000005)
(7S,13E,16S,17R,18S,19E)-22-oxa-(12)-cytochalasa-6(12),13,19-triene-1,21-dione-7,17-dihydroxy-16,18-dimethyl-10-phenyl|cytochalasin Z7
C28H35NO5 (465.25151000000005)
Thr Ala Phe Lys
C22H35N5O6 (465.25872100000004)
Ala Phe Thr Lys
C22H35N5O6 (465.25872100000004)
C25H39NO7_(7E)-6-Hydroperoxy-11,12-dihydroxy-3-isobutyl-13-methoxy-4,5,8-trimethyl-3,3a,6,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione
Ala Phe Lys Thr
C22H35N5O6 (465.25872100000004)
Ala Phe Gln Thr
Ala Phe Thr Gln
Ala Gly Arg Tyr
Ala Gly Tyr Arg
Ala Lys Phe Thr
C22H35N5O6 (465.25872100000004)
Ala Lys Thr Phe
C22H35N5O6 (465.25872100000004)
Ala Asn Val Tyr
Ala Asn Tyr Val
Ala Gln Phe Thr
Ala Gln Thr Phe
Ala Arg Gly Tyr
Ala Arg Tyr Gly
Ala Thr Phe Lys
C22H35N5O6 (465.25872100000004)
Ala Thr Phe Gln
Ala Thr Lys Phe
C22H35N5O6 (465.25872100000004)
Ala Thr Gln Phe
Ala Val Asn Tyr
Ala Val Tyr Asn
Ala Tyr Gly Arg
Ala Tyr Asn Val
Ala Tyr Arg Gly
Ala Tyr Val Asn
Asp Phe Gly Lys
Asp Phe Lys Gly
Asp Gly Phe Lys
Asp Gly Lys Phe
Asp Lys Phe Gly
Asp Lys Gly Phe
Phe Ala Lys Thr
C22H35N5O6 (465.25872100000004)
Phe Ala Gln Thr
Phe Ala Thr Lys
C22H35N5O6 (465.25872100000004)
Phe Ala Thr Gln
Phe Asp Gly Lys
Phe Asp Lys Gly
Phe Gly Asp Lys
Phe Gly Lys Asp
Phe Gly Arg Ser
Phe Gly Ser Arg
Phe Lys Ala Thr
C22H35N5O6 (465.25872100000004)
Phe Lys Asp Gly
Phe Lys Gly Asp
Phe Lys Thr Ala
C22H35N5O6 (465.25872100000004)
Phe Asn Ser Val
Phe Asn Val Ser
Phe Gln Ala Thr
Phe Gln Thr Ala
Phe Arg Gly Ser
Phe Arg Ser Gly
Phe Ser Gly Arg
Phe Ser Asn Val
Phe Ser Arg Gly
Phe Ser Val Asn
Phe Thr Ala Lys
C22H35N5O6 (465.25872100000004)
Phe Thr Ala Gln
Phe Thr Lys Ala
C22H35N5O6 (465.25872100000004)
Phe Thr Gln Ala
Phe Val Asn Ser
Phe Val Ser Asn
Gly Ala Arg Tyr
Gly Ala Tyr Arg
Gly Asp Phe Lys
Gly Asp Lys Phe
Gly Phe Asp Lys
Gly Phe Lys Asp
Gly Phe Arg Ser
Gly Phe Ser Arg
Gly His Pro Arg
Gly His Arg Pro
Gly Ile Asn Tyr
Gly Ile Tyr Asn
Gly Lys Asp Phe
Gly Lys Phe Asp
Gly Lys Val Tyr
C22H35N5O6 (465.25872100000004)
Gly Lys Tyr Val
C22H35N5O6 (465.25872100000004)
Gly Leu Asn Tyr
Gly Leu Tyr Asn
Gly Asn Ile Tyr
Gly Asn Leu Tyr
Gly Asn Tyr Ile
Gly Asn Tyr Leu
Gly Pro His Arg
Gly Pro Arg His
Gly Gln Val Tyr
Gly Gln Tyr Val
Gly Arg Ala Tyr
Gly Arg Phe Ser
Gly Arg His Pro
Gly Arg Pro His
Gly Arg Ser Phe
Gly Arg Tyr Ala
Gly Ser Phe Arg
Gly Ser Arg Phe
Gly Val Lys Tyr
C22H35N5O6 (465.25872100000004)
Gly Val Gln Tyr
Gly Val Tyr Lys
C22H35N5O6 (465.25872100000004)
Gly Val Tyr Gln
Gly Tyr Ala Arg
Gly Tyr Ile Asn
Gly Tyr Lys Val
C22H35N5O6 (465.25872100000004)
Gly Tyr Leu Asn
Gly Tyr Asn Ile
Gly Tyr Asn Leu
Gly Tyr Gln Val
Gly Tyr Arg Ala
Gly Tyr Val Lys
C22H35N5O6 (465.25872100000004)
Gly Tyr Val Gln
His Gly Pro Arg
His Gly Arg Pro
His Asn Pro Val
His Asn Val Pro
His Pro Gly Arg
His Pro Asn Val
His Pro Arg Gly
His Pro Val Asn
His Arg Gly Pro
His Arg Pro Gly
His Val Asn Pro
His Val Pro Asn
Ile Gly Asn Tyr
Ile Gly Tyr Asn
Ile Asn Gly Tyr
Ile Asn Tyr Gly
Ile Tyr Gly Asn
Ile Tyr Asn Gly
Lys Ala Phe Thr
C22H35N5O6 (465.25872100000004)
Lys Ala Thr Phe
C22H35N5O6 (465.25872100000004)
Lys Asp Phe Gly
Lys Asp Gly Phe
Lys Phe Ala Thr
C22H35N5O6 (465.25872100000004)
Lys Phe Asp Gly
Lys Phe Gly Asp
Lys Phe Thr Ala
C22H35N5O6 (465.25872100000004)
Lys Gly Asp Phe
Lys Gly Phe Asp
Lys Gly Val Tyr
C22H35N5O6 (465.25872100000004)
Lys Gly Tyr Val
C22H35N5O6 (465.25872100000004)
Lys Met Ser Thr
C18H35N5O7S (465.22570800000005)
Lys Met Thr Ser
C18H35N5O7S (465.22570800000005)
Lys Ser Met Thr
C18H35N5O7S (465.22570800000005)
Lys Ser Thr Met
C18H35N5O7S (465.22570800000005)
Lys Thr Ala Phe
C22H35N5O6 (465.25872100000004)
Lys Thr Phe Ala
C22H35N5O6 (465.25872100000004)
Lys Thr Met Ser
C18H35N5O7S (465.22570800000005)
Lys Thr Ser Met
C18H35N5O7S (465.22570800000005)
Lys Val Gly Tyr
C22H35N5O6 (465.25872100000004)
Lys Val Tyr Gly
C22H35N5O6 (465.25872100000004)
Lys Tyr Gly Val
C22H35N5O6 (465.25872100000004)
Lys Tyr Val Gly
C22H35N5O6 (465.25872100000004)
Leu Gly Asn Tyr
Leu Gly Tyr Asn
Leu Asn Gly Tyr
Leu Asn Tyr Gly
Leu Tyr Gly Asn
Leu Tyr Asn Gly
Met Lys Ser Thr
C18H35N5O7S (465.22570800000005)
Met Lys Thr Ser
C18H35N5O7S (465.22570800000005)
Met Ser Lys Thr
C18H35N5O7S (465.22570800000005)
Met Ser Thr Lys
C18H35N5O7S (465.22570800000005)
Met Thr Lys Ser
C18H35N5O7S (465.22570800000005)
Met Thr Ser Lys
C18H35N5O7S (465.22570800000005)
Asn Ala Val Tyr
Asn Ala Tyr Val
Asn Phe Ser Val
Asn Phe Val Ser
Asn Gly Ile Tyr
Asn Gly Leu Tyr
Asn Gly Tyr Ile
Asn Gly Tyr Leu
Asn His Pro Val
Asn His Val Pro
Asn Ile Gly Tyr
Asn Ile Tyr Gly
Asn Leu Gly Tyr
Asn Leu Tyr Gly
Asn Pro His Val
Asn Pro Val His
Asn Ser Phe Val
Asn Ser Val Phe
Asn Val Ala Tyr
Asn Val Phe Ser
Asn Val His Pro
Asn Val Pro His
Asn Val Ser Phe
Asn Val Tyr Ala
Asn Tyr Ala Val
Asn Tyr Gly Ile
Asn Tyr Gly Leu
Asn Tyr Ile Gly
Asn Tyr Leu Gly
Asn Tyr Val Ala
Pro Gly His Arg
Pro Gly Arg His
Pro His Gly Arg
Pro His Asn Val
Pro His Arg Gly
Pro His Val Asn
Pro Asn His Val
Pro Asn Val His
Pro Pro Pro Arg
C21H35N7O5 (465.26995400000004)
Pro Pro Arg Pro
C21H35N7O5 (465.26995400000004)
Pro Arg Gly His
Pro Arg His Gly
Pro Arg Pro Pro
C21H35N7O5 (465.26995400000004)
Pro Val His Asn
Pro Val Asn His
Gln Ala Phe Thr
Gln Ala Thr Phe
Gln Phe Ala Thr
Gln Phe Thr Ala
Gln Gly Val Tyr
Gln Gly Tyr Val
Gln Thr Ala Phe
Gln Thr Phe Ala
Gln Val Gly Tyr
Gln Val Tyr Gly
Gln Tyr Gly Val
Gln Tyr Val Gly
Arg Ala Gly Tyr
Arg Ala Tyr Gly
Arg Phe Gly Ser
Arg Phe Ser Gly
Arg Gly Ala Tyr
Arg Gly Phe Ser
Arg Gly His Pro
Arg Gly Pro His
Arg Gly Ser Phe
Arg Gly Tyr Ala
Arg His Gly Pro
Arg His Pro Gly
Arg Pro Gly His
Arg Pro His Gly
Arg Pro Pro Pro
C21H35N7O5 (465.26995400000004)
Arg Ser Phe Gly
Arg Ser Gly Phe
Arg Tyr Ala Gly
Arg Tyr Gly Ala
Ser Phe Gly Arg
Ser Phe Asn Val
Ser Phe Arg Gly
Ser Phe Val Asn
Ser Gly Phe Arg
Ser Gly Arg Phe
Ser Lys Met Thr
C18H35N5O7S (465.22570800000005)
Ser Lys Thr Met
C18H35N5O7S (465.22570800000005)
Ser Met Lys Thr
C18H35N5O7S (465.22570800000005)
Ser Met Thr Lys
C18H35N5O7S (465.22570800000005)
Ser Asn Phe Val
Ser Asn Val Phe
Ser Arg Phe Gly
Ser Arg Gly Phe
Ser Thr Lys Met
C18H35N5O7S (465.22570800000005)
Ser Thr Met Lys
C18H35N5O7S (465.22570800000005)
Ser Val Phe Asn
Thr Ala Lys Phe
C22H35N5O6 (465.25872100000004)
Thr Phe Ala Lys
C22H35N5O6 (465.25872100000004)
Thr Phe Lys Ala
C22H35N5O6 (465.25872100000004)
Thr Lys Ala Phe
C22H35N5O6 (465.25872100000004)
Thr Lys Phe Ala
C22H35N5O6 (465.25872100000004)
Thr Lys Met Ser
C18H35N5O7S (465.22570800000005)
Thr Lys Ser Met
C18H35N5O7S (465.22570800000005)
Thr Met Lys Ser
C18H35N5O7S (465.22570800000005)
Thr Met Ser Lys
C18H35N5O7S (465.22570800000005)
Thr Ser Lys Met
C18H35N5O7S (465.22570800000005)
Thr Ser Met Lys
C18H35N5O7S (465.22570800000005)
Val Gly Lys Tyr
C22H35N5O6 (465.25872100000004)
Val Gly Tyr Lys
C22H35N5O6 (465.25872100000004)
Val His Asn Pro
Val His Pro Asn
Val Lys Gly Tyr
C22H35N5O6 (465.25872100000004)
Val Lys Tyr Gly
C22H35N5O6 (465.25872100000004)
Val Asn His Pro
Val Asn Pro His
Val Pro His Asn
Val Pro Asn His
Val Tyr Gly Lys
C22H35N5O6 (465.25872100000004)
Val Tyr Lys Gly
C22H35N5O6 (465.25872100000004)
Tyr Ala Gly Arg
Tyr Ala Arg Gly
Tyr Gly Ala Arg
Tyr Gly Lys Val
C22H35N5O6 (465.25872100000004)
Tyr Gly Arg Ala
Tyr Gly Val Lys
C22H35N5O6 (465.25872100000004)
Tyr Lys Gly Val
C22H35N5O6 (465.25872100000004)
Tyr Lys Val Gly
C22H35N5O6 (465.25872100000004)
Tyr Arg Ala Gly
Tyr Arg Gly Ala
Tyr Val Gly Lys
C22H35N5O6 (465.25872100000004)
Tyr Val Lys Gly
C22H35N5O6 (465.25872100000004)
PC(14:1/0:0)
C22H44NO7P (465.28552440000004)
PC(14:2l8,8/0:0)[U]
C22H44NO7P (465.28552440000004)
AZD8055
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. AZD-8055 inhibits both mTORC1 and mTORC2[1]. AZD-8055 is a potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. AZD-8055 inhibits both mTORC1 and mTORC2[1].
tert-Butyl (E)-7-[3-(4-fluorophenyl)-1-methylethyl-indol-2-yl]-3-hydroxy-5-oxo-6-heptenoate
KU-0063794
D004791 - Enzyme Inhibitors KU-0063794 is a potent and specific mTOR inhibitor, inhibiting both the mTORC1 and mTORC2 complexes with IC50s of 10 nM. KU-0063794 is a potent and specific mTOR inhibitor, inhibiting both the mTORC1 and mTORC2 complexes with IC50s of 10 nM.
tert-Butyl (E)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-5-hydroxy-3-oxo-6-heptenoate
Mebeverine hydrochloride
C25H36ClNO5 (465.22818760000007)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
n-2-nitrophenylsulfenyl-l-isoleucine dicyclohexylammonium salt
C24H39N3O4S (465.26611340000005)
N-[(9R)-6-Methoxycinchonan-9-yl]-N-[(2S)-2-pyrrolidinylMethyl]-Thiourea
C26H35N5OS (465.25621800000005)
Phenylalanyl-glycyl-leucyl-methioninamide
C22H35N5O4S (465.2409630000001)
Luminespib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
1-(1-Adamantyl)-3-[8-[[1-(2-furanylmethyl)-5-tetrazolyl]methyl]-8-azabicyclo[3.2.1]octan-3-yl]urea
1-(10z-Heptadecenoyl)-sn-glycero-3-phosphoethanolamine
C22H44NO7P (465.28552440000004)
3alpha-hydroxyetiocholan-17-one 3-O-(beta-D-glucuronate)
3-oxo-5alpha-androstan-17beta-yl beta-D-glucopyranosiduronate
[5-[2-[(2R,6R)-2,6-dimethylmorpholin-4-yl]-4-morpholin-4-ylpyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol
(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35N3O4 (465.26274300000006)
(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35N3O4 (465.26274300000006)
2-[(1R,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
[(E)-[(1R,4aR,4bS,8aS,10aS)-4b,8,8,10a-tetramethyl-1-[2-(5-oxo-1,2-dihydropyrrol-4-yl)ethyl]-1,3,4,4a,5,6,7,8a,9,10-decahydrophenanthren-2-ylidene]methyl] hydrogen sulfate
C25H39NO5S (465.25488040000005)
2-cyclopropyl-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C27H35N3O4 (465.26274300000006)
2-cyclopropyl-N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C27H35N3O4 (465.26274300000006)
2-cyclopropyl-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C27H35N3O4 (465.26274300000006)
2-cyclopropyl-N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C27H35N3O4 (465.26274300000006)
2-cyclopropyl-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C27H35N3O4 (465.26274300000006)
N-[(1R,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
(2S,3S,3aR,9bR)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(4-methoxyphenyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C27H35N3O4 (465.26274300000006)
(1R,9S,10S,11S)-5-(cyclopenten-1-yl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H30F3N3O3 (465.22391460000006)
2-cyclopropyl-N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C27H35N3O4 (465.26274300000006)
2-cyclopropyl-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C27H35N3O4 (465.26274300000006)
N-[(1S,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]pyridine-3-carboxamide
(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-7-(4-methoxyphenyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C27H35N3O4 (465.26274300000006)
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35N3O4 (465.26274300000006)
(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(2-methoxyphenyl)ethynyl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H35N3O4 (465.26274300000006)
2-methoxy-N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C23H35N3O7 (465.24748800000003)
2-methoxy-N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C23H35N3O7 (465.24748800000003)
2-methoxy-N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C23H35N3O7 (465.24748800000003)
N-[(1S,3S,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(1R,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1S,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1S,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1S,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-cyclopropyl-1-[(1R)-2-(2-cyclopropyl-1-oxoethyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C27H35N3O4 (465.26274300000006)
1-[(1R)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone
C27H32FN3O3 (465.24275739999996)
1-[(1R)-2-[cyclopentyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-cyclopropylethanone
C27H35N3O4 (465.26274300000006)
5-(4,6-dioxo-3-propan-2-yl-1-cyclohex-2-enylidene)-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-2H-isoxazole-3-carboxamide
2-cyclopropyl-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C27H35N3O4 (465.26274300000006)
2-methoxy-N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C23H35N3O7 (465.24748800000003)
2-methoxy-N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C23H35N3O7 (465.24748800000003)
2-methoxy-N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C23H35N3O7 (465.24748800000003)
2-methoxy-N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C23H35N3O7 (465.24748800000003)
N-[(1R,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-[(1S,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1R,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1R,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[oxo(3-pyridinyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2,3-dihydro-1H-inden-2-yl)acetamide
(1S,9R,10R,11R)-5-(cyclopenten-1-yl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-12-(3,3,3-trifluoropropyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C24H30F3N3O3 (465.22391460000006)
(1R,9S,10S,11S)-N-cyclobutyl-12-[2-(dimethylamino)acetyl]-10-(hydroxymethyl)-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-N-cyclobutyl-12-[2-(dimethylamino)acetyl]-10-(hydroxymethyl)-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
4-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-(1-oxo-2-phenylethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
3-[4-[(8R,9R,10R)-10-(hydroxymethyl)-6-(1-oxo-2-phenylethyl)-1,6-diazabicyclo[6.2.0]decan-9-yl]phenyl]benzonitrile
2-cyclopropyl-1-[(1S)-2-(2-cyclopropyl-1-oxoethyl)-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
C27H35N3O4 (465.26274300000006)
1-[(1S)-2-[cyclopentyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-cyclopropylethanone
C27H35N3O4 (465.26274300000006)
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
17-oxo-5beta-androstan-3beta-yl beta-D-glucopyranosiduronate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-heptadec-10-enoate
C22H44NO7P (465.28552440000004)
N-(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)-2-[[2-[(2-amino-3-phenylpropanoyl)amino]acetyl]amino]-4-methylpentanamide
C22H35N5O4S (465.2409630000001)
[2-hydroxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C22H44NO7P (465.28552440000004)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-heptadec-9-enoate
C22H44NO7P (465.28552440000004)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] acetate
C22H44NO7P (465.28552440000004)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] butanoate
C22H44NO7P (465.28552440000004)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] propanoate
C22H44NO7P (465.28552440000004)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-tridec-9-enoate
C21H40NO8P (465.24914100000007)
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate
C21H40NO8P (465.24914100000007)
[2-[[(E)-10,16-dichlorohexadec-4-enoyl]-methylamino]-3-methoxypropyl] acetate
C23H41Cl2NO4 (465.24124860000006)
1-(9Z-tetradecenoyl)-sn-glycero-3-phosphocholine
C22H44NO7P (465.28552440000004)
1-(9Z-heptadecenoyl)-sn-glycero-3-phosphoethanolamine
C22H44NO7P (465.28552440000004)
5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide)(1-)
A steroid glucuronide anion that is the conjugate base of 5alpha-dihydrotestosterone 17-O-(beta-D-glucuronide) arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
lysophosphatidylcholine 14:1
C22H44NO7P (465.28552440000004)
A lysophosphatidylcholine in which the remaining acyl group contains 14 carbons and 1 double bond. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
lysophosphatidylcholine 14:1(9Z)/0:0
C22H44NO7P (465.28552440000004)
A lysophosphatidylcholine 14:1 in which the remaining acyl group is (9Z)-tetradecenoyl.
etiocholanolone 3-glucuronide(1-)
A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of etiocholanolone 3-glucuronide.
PE(16:1)
C21H40NO8P (465.24914100000007)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(14:1)
C22H44NO7P (465.28552440000004)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1s,2s,3s,4s,5s,6r,8s,9r,10s,13s,16r,17r)-11-ethyl-8,9,16-trihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
11-ethyl-4,16,18-trihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-8-yl acetate
n-(6-{2-[(3s,8as)-1-hydroxy-4-oxo-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-3-yl]acetyl}-2,2-dimethylchromen-5-yl)-2,2-dimethylbut-3-enamide
1,22-dihydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-8-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁴,⁹.0¹⁴,²².0¹⁶,²⁰]tricosa-2,4(9),5,10-tetraene-15,21-dione
(8e,22e)-27-methoxy-2-oxa-11,16,20-triazatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3(29),4,6,8,10,20,22,24,27-decaene-4,10,21-triol
(1r,13s,16s,22s,25s)-25-(hydroxymethyl)-7,7,26,26-tetramethyl-6,24-dioxa-12,14,20-triazaheptacyclo[11.10.3.0¹,¹³.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]hexacosa-2(11),3,5(10),8-tetraene-15,21-dione
1,8a-dihydroxy-3-{[7-hydroxy-2,2-dimethyl-6-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyrrol-6-yl]methyl}-3h,6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one
(1r,2s,3s,4s,5r,6s,8r,12s,13s,16r,19s,20r,21s)-14-ethyl-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane-2,21-diol
11-ethyl-8,9-dihydroxy-4,6,16-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-yl acetate
n-(3-chloro-2-{3-methyl-2-oxo-7-oxabicyclo[4.1.0]hept-3-en-1-yl}prop-2-en-1-yl)-7-methoxy-n-methyltetradec-4-enamide
C26H40ClNO4 (465.2645710000001)
11-ethyl-8,9,16-trihydroxy-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
1,8a-dihydroxy-3-{[(6s)-7-hydroxy-2,2-dimethyl-6-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyrrol-6-yl]methyl}-3h,6h,7h,8h-pyrrolo[1,2-a]pyrazin-4-one
(1r,2s,3s,4s,5s,6s,8r,12r,13s,16s,19s,20r)-14-ethyl-6,19-dimethoxy-16-(methoxymethyl)-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane-2,4-diol
2-hydroxy-n-{1-[2-(2-isopropyl-3-methoxy-5-oxo-2h-pyrrole-1-carbonyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}-3-methylpentanimidic acid
5-{[(2e,6e,10s)-11-chloro-10-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]oxy}-4,6-dimethoxy-3h-isoindol-1-ol
C25H36ClNO5 (465.22818760000007)
5-(2-{1-[2-(4-hydroxyphenyl)ethyl]-2,5-dioxopyrrol-3-yl}ethyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
C28H35NO5 (465.25151000000005)
1,16-dihydroxy-7,7-dimethyl-13-(2-methylbut-3-en-2-yl)-6-oxa-12,14,20-triazahexacyclo[11.10.0.0²,¹¹.0⁵,¹⁰.0¹⁴,²².0¹⁶,²⁰]tricosa-2(11),3,5(10),8-tetraene-15,21-dione
5a,8,8,11a-tetramethyl-1-oxo-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-9-yl propanoate
C28H35NO5 (465.25151000000005)
20-benzyl-6,22-dihydroxy-17,18-dimethyl-2,16-dioxa-21-azatetracyclo[12.8.0.0¹,¹⁹.0¹⁵,¹⁷]docosa-4,12,21-trien-3-one
C28H35NO5 (465.25151000000005)
14-benzyl-6,11,16-trihydroxy-5,7,13-trimethyl-12-methylidene-5h,6h,7h,8h,10ah,11h,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one
C28H35NO5 (465.25151000000005)